ViiV Healthcare says cabotegravir is superior to oral standard of care for HIV prevention in women

This article was originally published here

Following a pre-specified interim analysis, the DSMB indicated that cabotegravir met the primary objective of demonstrating superiority when compared to the current standard of care for women, daily

The post ViiV Healthcare says cabotegravir is superior to oral standard of care for HIV prevention in women appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply